急性冠状动脉综合征的标志物:穿皮冠状动脉干预时的距离冠状动脉栓塞
Niya Emilova Semerdzhieva1, Simeon Dimitrov2, Adelina Tsakova3
1Clinic of Internal Medicine, University Emergency Hospital 'Pirogov', 1606 Sofia, Bulgaria.
Journal of cardiovascular development and disease
|August 27, 2025
概括
在急性冠状动脉综合征 (ACS) 的皮肤冠状动脉干预 (PCI) 期间,远端冠状动脉栓塞与血流缓慢有关. 脱水二酸盐 (DHEA- S) 的升高可能表明风险,而较高的甘油三水平与PCI后的缓慢流动有关.
科学领域:
- 心血管医学
- 干预心脏病学
- 生物化学
背景情况:
- 在高达30. 5%的急性心肌梗塞 (AMI) 患者中,远端冠状动脉栓塞会使皮肤冠状动脉干预 (PCI) 复杂化.
- 这些栓塞与心肌再注血在心脏病相关的动脉区域的损伤有关.
- 鉴定远端冠状动脉栓塞的指标对于改善急性冠状动脉综合征 (ACS) 的PCI结果至关重要.
研究的目的:
- 在PCI过程中通过血管学检测到的远端冠状动脉栓塞的实验室,临床和成像指标.
- 分析各种生物标志物与在接受支架的ACS患者中偏角冠状动脉栓塞的发生率之间的关系.
主要方法:
- 对137名经过PCI与支架植入的ACS患者的分析.
- 测量心脏酶,炎症标志物,性类固醇 (包括脱氨硫酸[DHEA-S]),血清脂质和氧化低密度脂蛋白 (oxLDL).
- 测量的生物标志物与远端冠状动脉栓塞和慢冠状动脉流量发生率的相关性.
主要成果:
- 在9. 4%的患者中观察到冠状动脉血流缓慢.
- 甘油三 (TG),高密度脂蛋白 (HDL),葡萄糖和DHEA- S水平与远端冠状动脉栓塞和缓慢流动有关.
- 在多变量分析中,只有PCI后的DHEA- S显示出偏距冠状动脉栓塞风险的趋势 (p=0. 071).
结论:
- 在ACS患者中,较高的甘油三水平可能会增加PCI后血流缓慢的风险.
- 较高的DHEA- S水平可能反映与ACS和冠状动脉干预相关的交上腺和下丘脑- 上腺过活.
- 需要进一步的研究来阐明DHEA-S和其他生物标志物在预测远端冠状动脉栓塞中的作用.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:29Pulmonary Embolism I: Introduction
45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332